Bisphosphonates, cancer, and osteonecrosis--a single practice experience
- PMID: 15957261
Bisphosphonates, cancer, and osteonecrosis--a single practice experience
Abstract
Intravenous bisphosphonates have come into increasing use to protect cancer patients from adverse boney events. The prevalence of use, demographics of a treatment population, and occurrence of a particular side effect are explored in this article.
Similar articles
-
Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.J Oral Maxillofac Surg. 2007 Aug;65(8):1650-4. doi: 10.1016/j.joms.2007.03.021. J Oral Maxillofac Surg. 2007. PMID: 17656297 No abstract available.
-
Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.Am J Otolaryngol. 2007 May-Jun;28(3):158-63. doi: 10.1016/j.amjoto.2006.08.004. Am J Otolaryngol. 2007. PMID: 17499130
-
Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.J Oral Pathol Med. 2005 Nov;34(10):613-7. doi: 10.1111/j.1600-0714.2005.00351.x. J Oral Pathol Med. 2005. PMID: 16202082
-
Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Jul;102(1):14-21. doi: 10.1016/j.tripleo.2005.10.045. Epub 2006 Mar 20. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006. PMID: 16831667 Review.
-
Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.Gen Dent. 2006 May-Jun;54(3):215-9; quiz 220-2. Gen Dent. 2006. PMID: 16776417 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical